Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$108,308,538
+$89,219,804 QoQ
Shares Held
90,300
+260.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.77%
of 13F equity value
Holder Rank
#369
of 4,605 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSSIAM holds $190,268,884 across 10 Drug Manufacturers - General names. LLY ranks #1 (56.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
90,300 | $108,308,538 | |
| 2 | AZN |
Astrazeneca PLC
|
80,256 | $15,218,142 | |
| 3 | AMGN |
Amgen Inc
|
36,294 | $13,142,783 | |
| 4 | ABBV |
AbbVie Inc.
|
50,502 | $12,708,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
91,787 | $11,794,629 | |
| 6 | BIIB |
Biogen Inc.
|
39,223 | $8,474,521 | |
| 7 | PFE |
Pfizer Inc
|
275,753 | $6,640,132 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
49,573 | $6,263,052 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,308,538 | 90,300 | Shares | Defined | 2026-08-13 | |
| 2025-09-30 | $19,088,734 | 25,018 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $43,392,537 | 55,665 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $229,561,684 | 277,950 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $56,701,856 | 73,448 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $152,381,680 | 172,000 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $67,157,466 | 74,176 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $70,541,523 | 90,675 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $41,171,056 | 70,629 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $58,613,774 | 109,124 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $99,225,381 | 211,577 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $43,818,674 | 127,595 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $26,514,619 | 72,476 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,192,313 | 6,780 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,231 | 121 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,678,152 | 26,812 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,569,616 | 23,784 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,204,401 | 22,525 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,208,708 | 18,337 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,977,584 | 21,291 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,668,543 | 45,419 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $159,269 | 1,076 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $690,376 | 4,205 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,059,404 | 7,637 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||